The #1 Bottleneck in Drug Development Isn’t Science
Why do new drugs and medical breakthroughs take so long to reach real people? In this episode of The Disruption Lab, we sit down with Kyle McAllister, founder of trially, an AI-driven clinical trials company, to unpack the uncomfortable truth: the biggest bottleneck in clinical trials isn’t innovation — it’s patient recruitment. And in many hospitals, that process still looks like teams of research staff manually reading patient charts line-by-line to find eligible participants. Kyle shares how his “lived experience” inside electronic health records (EHRs) and hospital data systems pushed him…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.